Form 8-K - Current report:
SEC Accession No. 0001493152-25-010921
Filing Date
2025-03-19
Accepted
2025-03-19 16:15:33
Documents
16
Period of Report
2025-03-17
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42422
2 ex3-1.htm EX-3.1 1603
3 ex3-1_001.jpg GRAPHIC 838756
4 ex3-1_002.jpg GRAPHIC 3301820
  Complete submission text file 0001493152-25-010921.txt   5925305

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hepa-20250317.xsd EX-101.SCH 3027
6 XBRL LABEL FILE hepa-20250317_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE hepa-20250317_pre.xml EX-101.PRE 24173
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3813
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

EIN.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 25752937
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)